Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli.
Aunins TR, Erickson KE, Chatterjee A. Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30699-30709.